PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7659444-3	1995	In mice, the NK1 antagonist, CP 99,994, preferentially (inhibitory dose50 (ID50) = 4.4) inhibited the late phase (LP) as compared to the early phase (EP) (16.1) of formalin-induced licking (FIL).	3-(2-methoxybenzylamino)-2-phenylpiperidine	29-38	tachykinin 1	Mus musculus	13-16	
10454146-4	1999	In addition, the intraplantar application of CP-99994 (1 pmol), a substance P (NK1) receptor antagonist, but not CP-100263 (1 pmol), an inactive derivative, also markedly reduced the LPA responses.	3-(2-methoxybenzylamino)-2-phenylpiperidine	45-53	tachykinin 1	Mus musculus	66-77	
9190858-7	1997	The more potent inhibitor of [3H] SP binding, (+)-(2S,3S)-3-(2-methoxybenzylamino)-2-phenylpiperidine (CP-99,994), was approximately 10 times more potent in inhibiting NMDA-induced activity than CP-96,345.	3-(2-methoxybenzylamino)-2-phenylpiperidine	46-101	tachykinin 1	Mus musculus	34-36